Illinois Department of Public Health Adds New COVID-19 Treatment for Distribution Across Illinois
SPRINGFIELD – As a new COVID-19 treatment rolls out across the country, the Illinois Department of Public Health (IDPH) continues to distribute these life-saving therapeutics equitably across the state. On February 11, 2022, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization for a new monoclonal antibody, bebtelovimab, for the treatment of COVID-19. Bebtelovimab will now join another monoclonal antibody treatment, sotrovimab , two oral antivirals, Paxlovid and molnupiravir , and a preventive drug, Evusheld , in the list of COVID-19 treatments available across Illinois. “This newest COVID-19 treatment authorized by the FDA will continue to move us forward as we co-exist with COVID-19,” said IDPH Director Dr. Ngozi Ezike. “While vaccination and boosting are still the best protection against severe illness due to COVID-19, this new treatment, along with other previously authorized treatments, can help keep people out of th